Ichor Holdings
ICHR
$65.59
-7.97%
Ichor Holdings designs, engineers, and manufactures critical fluid delivery subsystems and components for semiconductor capital equipment, as well as for defense/aerospace and medical industries. The company is a niche player in the semiconductor supply chain, providing precision gas and chemical delivery systems essential for advanced manufacturing processes. The current investor narrative centers on the company's dramatic recovery and growth acceleration, driven by the semiconductor upcycle and increased capital equipment spending, despite recent volatility and profitability challenges. The stock has surged over 280% in the past year, reflecting strong demand and optimism about future earnings, but recent price swings indicate high uncertainty about the sustainability of this momentum.…
ICHR
Ichor Holdings
$65.59
Investment Opinion: Should I buy ICHR Today?
Rating: Buy. Ichor Holdings is a high-risk, high-reward opportunity with a strong analyst consensus (Strong Buy, average target $92.29) and a compelling valuation on a sales basis. The thesis is that the semiconductor upcycle will drive revenue growth and margin expansion, leading to a return to profitability and significant stock appreciation.
Sign up to view all
ICHR 12-Month Price Forecast
The AI model assesses ICHR as bullish with medium confidence. The improving revenue and margin trends, combined with a deeply discounted sales multiple, suggest the market is not fully pricing in the recovery. However, the high volatility and negative earnings introduce uncertainty. The stance would be upgraded to high confidence if the company delivers positive EPS and maintains gross margins above 12%. Conversely, a downgrade to neutral would occur if revenue growth stalls or margins deteriorate.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ichor Holdings's 12-month outlook, with a consensus price target around $93.00 and implied upside of +41.8% versus the current price.
Average Target
$93.00
0 analysts
Implied Upside
+41.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$72 - $125
Analyst target range
The wide target range suggests significant disagreement among analysts about Ichor's future prospects. The high target of $125.00 implies a belief in continued strong growth and margin expansion, potentially driven by the semiconductor upcycle and new product wins. The low target of $60.00 suggests concerns about competitive pressures, margin erosion, or a potential downturn in the semiconductor cycle. Recent ratings actions have been predominantly positive, with upgrades from Stifel (Hold to Buy) and reaffirmations of Buy ratings from multiple firms, indicating growing confidence in the company's turnaround story.
Bulls vs Bears: ICHR Investment Factors
Ichor Holdings presents a classic high-risk, high-reward turnaround story. The bull case is anchored on a strong semiconductor upcycle, improving revenue trends, and a deeply discounted sales multiple, while the bear case centers on persistent losses, thin margins, and extreme volatility. Currently, the evidence slightly favors the bulls given the strong analyst consensus and operational improvements, but the sustainability of the recovery is the key tension. If the company can continue to expand margins and achieve profitability, the stock has substantial upside; however, any stumble in the semiconductor cycle or margin execution could trigger a sharp sell-off. The most critical factor to watch is whether gross margins can hold above 11% and whether the company can deliver positive EPS in the coming quarters.
Bullish
- Massive revenue growth and recovery: Revenue surged to $256.1M in Q1 2026, up 4.75% YoY and 14.5% sequentially from Q4 2025's $223.6M, signaling a strong semiconductor upcycle. The 280% stock rally over the past year reflects investor confidence in sustained demand.
- Improving profitability trajectory: Net loss narrowed dramatically to $2.5M in Q1 2026 from $16.0M in Q4 2025, with gross margin expanding to 11.6% from 9.4%. Operating income turned positive at $2.7M, indicating operational leverage is kicking in.
- Undervalued on sales basis: Trailing PS ratio of 0.68 is far below the industry average of 4.5, suggesting the market is pricing in significant growth. Even with thin margins, the sales multiple implies substantial upside if profitability normalizes.
- Strong analyst conviction: Analysts rate ICHR a Strong Buy with a mean recommendation of 1.43, and the average price target of $92.29 implies 22.6% upside from the current $75.27. Recent upgrades from Stifel and reaffirmations signal growing confidence.
Bearish
- Persistent unprofitability: Despite revenue growth, ICHR has posted net losses for eight consecutive quarters, with a cumulative net loss of over $60M in the last two years. The company's net margin is -5.6%, and it remains dependent on future margin expansion to justify its valuation.
- Extreme volatility and drawdown risk: The stock has a beta of 1.78 and recently experienced a -44.6% max drawdown, with a 32.7% drop in the last month alone. This volatility makes it unsuitable for risk-averse investors and could lead to significant losses.
- High valuation on forward earnings: Forward PE of 27.9 is rich for a company with negative trailing earnings and thin gross margins. If the projected EPS of $3.87 is not achieved, the stock could face severe de-rating.
- Thin gross margins: Gross margin of 11.6% is well below industry norms, reflecting intense competition and cost pressures. Even a small increase in input costs could wipe out operating profits, as seen in Q3 2025 when gross margin fell to 4.6%.
ICHR Technical Analysis
Ichor Holdings is in a powerful long-term uptrend, with the stock up 280.3% over the past year, dramatically outperforming the S&P 500's 18.2% gain. The current price of $75.27 sits at 66.3% of its 52-week range (low $13.12, high $113.58), indicating the stock has pulled back significantly from its highs but remains well above its lows. This positioning suggests the market is still in a bullish phase, though the recent correction from the peak may signal profit-taking or a consolidation phase.
Beta
—
—
Max Drawdown
-44.6%
Largest decline past year
52-Week Range
$14-$114
Price range past year
Annual Return
+366.5%
Cumulative gain past year
| Period | ICHR Return | S&P 500 |
|---|---|---|
| 1m | -31.4% | +2.5% |
| 3m | -7.9% | +5.2% |
| 6m | +104.0% | +11.5% |
| 1y | +366.5% | +22.6% |
| ytd | +221.4% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ICHR Fundamental Analysis
Ichor's revenue has shown a mixed but improving trend, with the most recent quarter (Q1 2026) reporting $256.1 million, up 4.75% year-over-year, and a sequential increase from $223.6 million in Q4 2025. However, the company remains unprofitable, with a net loss of $2.5 million in Q1 2026, though this is a significant improvement from the $15.96 million loss in Q4 2025. Gross margin improved to 11.6% in Q1 2026 from 9.4% in Q4 2025, but remains thin, reflecting ongoing cost pressures and operational inefficiencies.
Quarterly Revenue
$256067999.0B
2026-03
Revenue YoY Growth
+4.8%
YoY Comparison
Gross Margin
11.6%
Latest Quarter
Free Cash Flow
$-16761000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ICHR Overvalued?
Given the negative trailing earnings (net income of -$2.5 million in Q1 2026), the price-to-sales (PS) ratio is the most appropriate valuation metric. Ichor's trailing PS ratio is 0.68, which is significantly lower than the industry average of 4.5, suggesting the stock is trading at a substantial discount to its peers on a sales basis. However, the forward PE ratio of 27.9 indicates that the market expects a strong earnings recovery, with analysts projecting EPS of $3.87 for the next fiscal year, which would justify a higher multiple if achieved.
PE
-12.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 6x~30x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-95.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are substantial. Ichor has been unprofitable for eight consecutive quarters, with a cumulative net loss of over $60 million in the last two years. The company's net margin is -5.6%, and its gross margin of 11.6% is razor-thin, leaving little room for error. While the debt-to-equity ratio of 0.28 is manageable, the company's negative free cash flow of -$16.8 million TTM indicates it is still burning cash, which could become problematic if the semiconductor cycle turns down. The reliance on a few large customers in the semiconductor capital equipment industry adds concentration risk, as a slowdown in capex could directly impact revenue.